ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

CREG Announced for Premorbid Psychological Factors Study

August 27, 1976

Cornel Student Withdraws In Wake Of Discrepancies Found In Study

September 18, 1981

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997

Biomedical Supercomputer Will Be Available To NIH, Extramural Scientists; No Payback Planned To Starts

July 13, 1984

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976